Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-119 manufacturers

Filters

Filters

Filters , active

Country of origin : China
1 products found

pp-119

Tablets, film coated

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
"Indication: Immune-mediated inflammatory diseases, including hidradenitis suppurativa (HS) and other conditions driven by dysregulated innate immune signaling; focus on patients with moderate-to-severe disease inadequately controlled by standard therapies Clinical stage: Phase 1b clinical development (ongoing), with Phase 2 planned Modality: Small molecule Mechanism / Target: Selective RIPK2 (Receptor-interacting serine/threonine-protein kinase 2) inhibitor, blocking NOD1/NOD2 signaling pathways and downstream NF-κB–mediated inflammatory cytokine production Route / form: Oral Differentiation: Oral, targeted inhibition of RIPK2 offers a novel mechanism to modulate innate immune signaling upstream of multiple inflammatory pathways; potential for improved safety versus broad immunosuppressants and applicability across multiple inflammatory indications; positioned as a first-in-class approach in diseases like hidradenitis suppurativa
Manufacturer #29779

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.